Rituximab Treatment and Long-term Outcome of Patients With Autoimmune Encephalitis: Real-world Evidence From the GENERATE Registry

To determine the real-world use of rituximab in autoimmune encephalitis (AE) and to correlate rituximab treatment with the long-term outcome. Patients with NMDA receptor (NMDAR)-AE, leucine-rich glioma-inactivated-1 (LGI1)- AE, contactin-associated protein-like-2 (CASPR2)-AE, or glutamic acid decarb...

Full description

Saved in:

Bibliographic Details
Published in:	Neurology : neuroimmunology & neuroinflammation Vol. 8; no. 6
Main Authors:	Thaler, Franziska S, Zimmermann, Luise, Kammermeier, Stefan, Strippel, Christine, Ringelstein, Marius, Kraft, Andrea, Sühs, Kurt-Wolfram, Wickel, Jonathan, Geis, Christian, Markewitz, Robert, Urbanek, Christian, Sommer, Claudia, Doppler, Kathrin, Penner, Loana, Lewerenz, Jan, Rößling, Rosa, Finke, Carsten, Prüss, Harald, Melzer, Nico, Wandinger, Klaus-Peter, Leypoldt, Frank, Kümpfel, Tania
Format:	Journal Article
Language:	English
Published:	United States Lippincott Williams & Wilkins 01-11-2021
Subjects:	Adult Aged Anti-N-Methyl-D-Aspartate Receptor Encephalitis - drug therapy Anti-N-Methyl-D-Aspartate Receptor Encephalitis - immunology Autoantibodies - immunology Autoimmune Diseases of the Nervous System - drug therapy Autoimmune Diseases of the Nervous System - immunology Encephalitis - drug therapy Encephalitis - immunology Female Follow-Up Studies Humans Immunosuppressive Agents - administration & dosage Immunosuppressive Agents - pharmacology Male Middle Aged Outcome Assessment, Health Care Registries Rituximab - administration & dosage Rituximab - pharmacology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!